Cellebrite DI Ltd. (NASDAQ:CLBT) Short Interest Down 17.1% in November

Cellebrite DI Ltd. (NASDAQ:CLBT) was the recipient of a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 1,450,000 shares, a decline of 17.1% from the November 15th total of 1,750,000 shares. Approximately 1.7% of the shares of the company are sold short. Based on an average trading volume of 1,300,000 shares, the short-interest ratio is currently 1.1 days.

Cellebrite DI Stock Up 2.1 %

Shares of CLBT stock traded up $0.41 during mid-day trading on Monday, reaching $20.29. The company’s stock had a trading volume of 571,074 shares, compared to its average volume of 1,177,320. The company’s 50 day simple moving average is $18.93 and its 200-day simple moving average is $15.82. The firm has a market capitalization of $4.18 billion, a PE ratio of -12.83, a price-to-earnings-growth ratio of 2.71 and a beta of 1.51. Cellebrite DI has a 12-month low of $7.91 and a 12-month high of $21.72.

Cellebrite DI (NASDAQ:CLBT) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.05. The company had revenue of $106.90 million for the quarter, compared to the consensus estimate of $102.06 million. Cellebrite DI had a positive return on equity of 122.59% and a negative net margin of 82.28%. Cellebrite DI’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.09 EPS. As a group, research analysts anticipate that Cellebrite DI will post 0.32 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of CLBT. Point72 Asia Singapore Pte. Ltd. boosted its holdings in shares of Cellebrite DI by 59.6% in the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,724 shares of the company’s stock valued at $33,000 after acquiring an additional 1,017 shares in the last quarter. Tower View Wealth Management LLC grew its holdings in Cellebrite DI by 1.2% during the third quarter. Tower View Wealth Management LLC now owns 130,647 shares of the company’s stock worth $2,200,000 after acquiring an additional 1,500 shares during the period. Quarry LP acquired a new stake in Cellebrite DI in the 3rd quarter valued at about $27,000. Advisors Asset Management Inc. raised its holdings in shares of Cellebrite DI by 130.5% in the 3rd quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company’s stock worth $52,000 after purchasing an additional 1,742 shares in the last quarter. Finally, Venturi Wealth Management LLC boosted its holdings in Cellebrite DI by 28.6% during the third quarter. Venturi Wealth Management LLC now owns 9,000 shares of the company’s stock worth $152,000 after buying an additional 2,000 shares in the last quarter. Institutional investors own 45.88% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. JPMorgan Chase & Co. boosted their price objective on shares of Cellebrite DI from $22.00 to $24.00 and gave the stock an “overweight” rating in a report on Monday. Needham & Company LLC lifted their price objective on Cellebrite DI from $17.00 to $21.00 and gave the stock a “buy” rating in a report on Thursday, November 7th. Craig Hallum raised their price target on Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Finally, TD Cowen boosted their price objective on shares of Cellebrite DI from $20.00 to $23.00 and gave the stock a “buy” rating in a research report on Monday, September 23rd. Eight equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $20.57.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.